Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Fresenius Medical Care AG & Co KGaA ADR

Start price
Target price
Perf. (%)
€17.20
06.04.24
-
06.04.25
8.14%
22.04.24

StockNews.com 
06.04.24 50%
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€25.07
04.04.24
-
04.04.25
10.37%
23.04.24

DirectorDealer 
04.04.24 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
01.04.24
€23.28
01.04.25
-
08.03.24

Wells Fargo & Company 
01.04.24 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
01.04.24
-
01.04.25
-
08.03.24

Cantor Fitzgerald 
01.04.24 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
01.04.24
€9.27
01.04.25
-
08.03.24

HC Wainwright 
01.04.24 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€14.68
29.03.24
€15.00
29.03.25
-1.16%
23.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Well known brand
Traumtanz 
29.03.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€27.13
26.03.24
€36.00
26.03.25
0.87%
23.04.24

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Snowman 
26.03.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.32
05.03.24
-
05.03.25
3.97%
23.04.24

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
fenjal 
05.03.24 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.63
04.03.24
€1.00
04.03.25
-12.50%
08.03.24

Could be worthwhile Investment >10% per year
melinda 
04.03.24 20%
sell
Evotec SE

Start price
Target price
Perf. (%)
€13.43
15.02.24
-
15.02.25
8.04%
23.04.24

DirectorDealer 
15.02.24 50%
buy
Bayer AG ADR

Start price
Target price
Perf. (%)
€7.25
06.02.24
€7.00
06.02.25
-6.21%
22.04.24

EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Traumtanz 
06.02.24 50%
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€10.75
02.02.24
-
02.02.25
25.12%
23.04.24

DirectorDealer 
02.02.24 50%
buy
Paul Hartmann AG

Start price
Target price
Perf. (%)
€228.00
01.02.24
-
01.02.25
-8.33%
23.04.24

DirectorDealer 
01.02.24 50%
sell
Fresenius Medical Care AG & Co KGaA ADR

Start price
Target price
Perf. (%)
€18.50
08.01.24
-
08.01.25
0.54%
22.04.24

Morgan Stanley 
08.01.24 50%
buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€92.80
03.01.24
-
03.01.25
10.02%
23.04.24

systinvest 
03.01.24 50%
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€44.00
03.01.24
-
03.01.25
0.00%
23.04.24

systinvest 
03.01.24 50%
sell
Affimed N.V.

Start price
Target price
Perf. (%)
€0.42
25.12.23
-
25.12.24
30.73%
08.03.24

StockNews.com 
25.12.23 50%
sell
Bayer AG ADR

Start price
Target price
Perf. (%)
€7.85
18.12.23
-
18.12.24
-13.38%
22.04.24

HSBC Holdings plc 
18.12.23 50%
sell
Affimed N.V.

Start price
Target price
Perf. (%)
€0.37
17.12.23
-
17.12.24
49.46%
08.03.24

StockNews.com 
17.12.23 50%
sell
Affimed N.V.

Start price
Target price
Perf. (%)
€0.40
09.12.23
-
09.12.24
38.94%
08.03.24

StockNews.com 
09.12.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€32.44
07.12.23
-
07.12.24
-15.65%
23.04.24

Sandokan 
07.12.23 50%
buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€3.84
06.12.23
-
06.12.24
-20.57%
23.04.24

Erntehelfer 
06.12.23 90%
buy
Bayer AG

Start price
Target price
Perf. (%)
€31.24
02.12.23
-
02.12.24
-12.41%
23.04.24

Joe130978 
02.12.23 50%
buy
Fresenius Medical Care AG & Co KGaA ADR

Start price
Target price
Perf. (%)
€17.70
17.11.23
-
17.11.24
5.08%
22.04.24

Societe Generale 
17.11.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€40.81
17.11.23
-
17.11.24
-32.95%
23.04.24

investresearch 
17.11.23 50%